Soluble aggregates of the amyloid-β protein activate endothelial monolayers for adhesion and subsequent transmigration of monocyte cells

Journal of Neurochemistry

Volumn 104, Issue 2, 2008, Pages 500-513

  Gonzalez Velasquez, Francisco J ^a   Moss, Melissa A ^a  

^a University of South Carolina   (United States)

Author keywords

Alzheimer's disease; Amyloid protein; Cell adhesion; Cerebral amyloid angiopathy; Soluble aggregates; Transendothelial migration

Indexed keywords

AMYLOID BETA PROTEIN; LIGAND; MONOMER; OLIGOMER;

ARTICLE; CELL ADHESION; CELL MIGRATION; CONTROLLED STUDY; CORRELATION ANALYSIS; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; MONOCYTE; MONOLAYER CULTURE; NEUROCHEMISTRY; NEUROPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN EXPRESSION; PROTEIN ISOLATION;

AMYLOID; AMYLOID BETA-PROTEIN; ANALYSIS OF VARIANCE; CELL ADHESION; CELL DEATH; CELL MOVEMENT; CELL SURVIVAL; CELLS, CULTURED; ENDOTHELIAL CELLS; HUMANS; MEMBRANE PROTEINS; MONOCYTES; PEPTIDE FRAGMENTS; PHOSPHOPROTEINS; TIME FACTORS; UMBILICAL VEINS; UP-REGULATION;

EID: 37349003744     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/j.1471-4159.2007.04988.x     Document Type: Article

References (59)

1. Barghorn S., Nimmrich V., Striebinger A. et al. (2005) Globular amyloid β-peptide oligomer - a homogenous and stable neuropathological protein in Alzheimer's disease. J. Neurochem. 95, 834 847.
2. Basta G., Lazzerini G., Massaro M., Simoncini T., Tanganelli P., Fu C., Kislinger T., Stern D. M., Schmidt A. M. De Caterina R. (2002) Advanced glycation end products activate endothelium through signal-transduction receptor RAGE: A mechanism for amplification of inflammatory responses. Circulation 105, 816 822.
3. Bierhaus A., Humpert P. M., Morcos M., Wendt T., Chavakis T., Arnold B., Stern D. M. Nawroth P. P. (2005) Understanding RAGE, the receptor for advanced glycation end products. J. Mol. Med. 83, 876 886.
4. Blanc E. M., Toborek M., Mark R. J., Hennig B. Mattson M. P. (1997) Amyloid β-peptide induces cell monolayer albumin permeability, impairs glucose transport, and induces apoptosis in vascular endothelial cells. J. Neurochem. 68, 1870 1881.
5. Blasko I., Stampfer-Kountchev M., Robatscher P., Veerhuis R., Eikelenboom P. Grubeck-Loebenstein B. (2004) How chronic inflammation can affect the brain and support the development of Alzheimer's disease in old age: the role of microglia and astrocytes. Aging Cell 3, 169 176.
6. Cleary J. P., Walsh D. M., Hofmeister J. J., Shankar G. M., Kuskowski M. A., Selkoe D. J. Ashe K. H. (2005) Natural oligomers of the amyloid-β protein specifically disrupt cognitive function. Nat. Neurosci. 8, 79 84.
7. Davis-Salinas J., Saporito-Irwin S. M., Cotman C. W. Van Nostrand W. E. (1995) Amyloid β-protein induces its own production in cultured degenerating cerebrovascular smooth muscle cells. J. Neurochem. 65, 931 934.
8. De Felice F. G., Wu D., Lambert M. P. et al. (2007) Alzheimer's disease-type neuronal tau hyperphosphorylation induced by Aβ oligomers. Neurobiol. Aging EPub ahead of print: doi:
9. Deane R. Zlokovic B. V. (2007) Role of the blood-brain barrier in the pathogenesis of Alzheimer's disease. Curr. Alzheimer Res. 4, 191 197.
10. Deshpande A., Mina E., Glabe C. Busciglio J. (2006) Different conformations of amyloid β induce neurotoxicity by distinct mechanisms in human cortical neurons. J. Neurosci. 26, 6011 6018.
11. Eisenhauer P. B., Johnson R. J., Wells J. M., Davies T. A. Fine R. E. (2000) Toxicity of various amyloid β peptide species in cultured human blood-brain barrier endothelial cells: Increased toxicity of dutch-type mutant. J. Neurosci. Res. 60, 804 810.
12. Essodaigui M., Broxterman H. J. Garnier-Suillerot A. (1998) Kinetic analysis of calcein and calcein-acetoxymethylester efflux mediated by the multidrug resistance protein and P-glycoprotein. Biochemistry 37, 2243 2250.
13. Floden A. M. Combs C. K. (2006) β-amyloid stimulates murine postnatal and adult microglia cultures in a unique manner. J. Neurosci. 26, 4644 4648.
14. Folin M., Baiguera S., Tommasini M., Guidolin D., Conconi M. T., De Carlo E., Nussdorfer G. G. Parnigotto P. P. (2005) Effects of β-amyloid on rat neuromicrovascular endothelial cells cultured in vitro. Int. J. Mol. Med. 15, 929 935.
15. Giri R., Shen Y., Stins M., Du Yan S., Schmidt A. M., Stern D., Kim K. S., Zlokovic B. Kalra V. K. (2000) β-amyloid-induced migration of monocytes across human brain endothelial cells involves RAGE and PECAM-1. Am. J. Physiol. Cell Physiol. 279, C1772 C1781.
16. Giri R., Selvaraj S., Miller C. A., Hofman F., Yan S. D., Stern D., Zlokovic B. V. Kalra V. K. (2002) Effect of endothelial cell polarity on β-amyloid-induced migration of monocytes across normal and AD endothelium. Am. J. Physiol. Cell Physiol. 283, C895 C904.
17. Grammas P., Yamada M. Zlokovic B. (2002) The cerebromicrovasculature: A key player in the pathogenesis of Alzheimer's disease. J Alzheimers Dis 4, 217 223.
18. Jellinger K. A. (2002) Alzheimer disease and cerebrovascular pathology: An update. J. Neural. Transm. 109, 813 836.
19. Jellinger K. A. Attems J. (2005) Prevalence and pathogenic role of cerebrovascular lesions in Alzheimer disease. J. Neurol. Sci. 229-230, 37 41.
20. Kaur C., Hao A. J., Wu C. H. Ling E. A. (2001) Origin of microglia. Microsc. Res. Tech. 54, 2 9.
21. Kirkitadze M. D., Bitan G. Teplow D. B. (2002) Paradigm shifts in Alzheimer's disease and other neurodegenerative disorders: The emerging role of oligomeric assemblies. J. Neurosci. Res. 69, 567 577.
22. Kitazawa M., Yamasaki T. R. LaFerla F. M. (2004) Microglia as a potential bridge between the amyloid β-peptide and tau. Ann. NY Acad. Sci. 1035, 85 103.
23. Klyubin I., Walsh D. M., Lemere C. A. et al. (2005) Amyloid β protein immunotherapy neutralizes Aβ oligomers that disrupt synaptic plasticity in vivo. Nat. Med. 11, 556 561.
24. Lesne S., Koh M. T., Kotilinek L., Kayed R., Glabe C. G., Yang A., Gallagher M. Ashe K. H. (2006) A specific amyloid-β protein assembly in the brain impairs memory. Nature 440, 352 357.
25. Lue L. F., Walker D. G. Rogers J. (2001) Modeling microglial activation in Alzheimer's disease with human postmortem microglial cultures. Neurobiol. Aging 22, 945 956.
26. Lue L. F., Yan S. D., Stern D. M. Walker D. G. (2005) Preventing activation of receptor for advanced glycation endproducts in Alzheimer's disease. Curr. Drug Targets CNS Neurol. Disord. 4, 249 266.
27. Maat-Schieman M. L., van Duinen S. G., Rozemuller A. J., Haan J. Roos R. A. (1997) Association of vascular amyloid β and cells of the mononuclear phagocyte system in hereditary cerebral hemorrhage with amyloidosis (Dutch) and Alzheimer disease. J. Neuropathol. Exp. Neurol. 56, 273 284.
28. Miao J., Xu F., Davis J., Otte-Holler I., Verbeek M. M. Van Nostrand W. E. (2005) Cerebral microvascular amyloid β protein deposition induces vascular degeneration and neuroinflammation in transgenic mice expressing human vasculotropic mutant amyloid β precursor protein. Am. J. Pathol. 167, 505 515.
29. Miravalle L., Tokuda T., Chiarle R., Giaccone G., Bugiani O., Tagliavini F., Frangione B. Ghiso J. (2000) Substitutions at codon 22 of Alzheimer's Aβ peptide induce diverse conformational changes and apoptotic effects in human cerebral endothelial cells. J. Biol. Chem. 275, 27110 27116.
30. 6 promotes β-amyloid(1-40) protofibril growth by association but does not alter protofibril effects on cellular reduction of 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT). Mol. Pharmacol. 64, 1160 1168.
31. Munoz F. J., Opazo C., Gil-Gomez G., Tapia G., Fernandez V., Valverde M. A. Inestrosa N. C. (2002) Vitamin E but not 17β-estradiol protects against vascular toxicity induced by β-amyloid wild type and the Dutch amyloid variant. J. Neurosci. 22, 3081 3089.
32. Murakami K., Irie K., Morimoto A., Ohigashi H., Shindo M., Nagao M., Shimizu T. Shirasawa T. (2002) Synthesis, aggregation, neurotoxicity, and secondary structure of various Aβ 1-42 mutants of familial Alzheimer's disease at positions 21-23. Biochem. Biophys. Res. Commun. 294, 5 10.
33. Nagele R. G., Wegiel J., Venkataraman V., Imaki H., Wang K. C. Wegiel J. (2004) Contribution of glial cells to the development of amyloid plaques in Alzheimer's disease. Neurobiol. Aging 25, 663 674.
34. Nichols M. R., Moss M. A., Reed D. K., Lin W.-L., Mukhopadhyay R., Hoh J. H. Rosenberry T. L. (2002) Growth of β-amyloid(1-40) protofibrils by monomer elongation and lateral association. Characterization of distinct products by light scattering and atomic force microscopy. Biochemistry 41, 6115 6127.
35. Paris D., Town T., Mori T., Parker T. A., Humphrey J. Mullan M. (2000) Soluble β-amyloid peptides mediate vasoactivity via activation of a pro-inflammatory pathway. Neurobiol. Aging 21, 183 197.
36. Paris D., Ait-Ghezala G., Mathura V. S., Patel N., Quadros A., Laporte V. Mullan M. (2005) Anti-angiogenic activity of the mutant Dutch Aβ peptide on human brain microvascular endothelial cells. Brain Res. Mol. Brain Res. 136, 212 230.
37. Pober J. S. Cotran R. S. (1990) Cytokines and endothelial cell biology. Physiol. Rev. 70, 427 451.
38. Rhodin J. A. Thomas T. (2001) A vascular connection to Alzheimer's disease. Microcirculation 8, 207 220.
39. Rhodin J. A., Thomas T. N., Clark L., Garces A. Bryant M. (2003) In vivo cerebrovascular actions of amyloid β-peptides and the protective effect of conjugated estrogens. J. Alzheimers Dis. 5, 275 286.
40. Roher A. E., Chaney M. O., Kuo Y.-M. et al. (1996) Morphology and toxicity of Aβ-(1-42) dimer derived from neuritic and vascular amyloid deposits of Alzheimer's disease. J. Biol. Chem. 271, 20631 20635.
41. Sastre M., Klockgether T. Heneka M. T. (2006) Contribution of inflammatory processes to Alzheimer's disease: molecular mechanisms. Int. J. Dev. Neurosci. 24, 167 176.
42. Schmidt A. M., Yan S. D., Yan S. F. Stern D. M. (2000) The biology of the receptor for advanced glycation end products and its ligands. Biochim. Biophys. Acta 1498, 99 111.
43. Shankar G. M., Bloodgood B. L., Townsend M., Walsh D. M., Selkoe D. J. Sabatini B. L. (2007) Natural oligomers of the Alzheimer amyloid-β protein induce reversible synapse loss by modulating an NMDA-type glutamate receptor-dependent signaling pathway. J. Neurosci. 27, 2866 2875.
44. Simard A. R. Rivest S. (2004) Bone marrow stem cells have the ability to populate the entire central nervous system into fully differentiated parenchymal microglia. FASEB J. 18, 998 1000.
45. Strazielle N., Ghersi-Egea J. F., Ghiso J., Dehouck M. P., Frangione B., Patlak C., Fenstermacher J. Gorevic P. (2000) In vitro evidence that β-amyloid peptide 1-40 diffuses across the blood-brain barrier and affects its permeability. J. Neuropathol. Exp. Neurol. 59, 29 38.
46. Su G. C., Arendash G. W., Kalaria R. N., Bjugstad K. B. Mullan M. (1999) Intravascular infusions of soluble β-amyloid compromise the blood-brain barrier, activate CNS glial cells and induce peripheral hemorrhage. Brain Res. 818, 105 117.
47. Suo Z., Tan J., Placzek A., Crawford F., Fang C. Mullan M. (1998) Alzheimer's β-amyloid peptides induce inflammatory cascade in human vascular cells: The roles of cytokines and CD40. Brain Res. 807, 110 117.
48. Townsend M., Shankar G. M., Mehta T., Walsh D. M. Selkoe D. J. (2006) Effects of secreted oligomers of amyloid β-protein on hippocampal synaptic plasticity: a potent role for trimers. J. Physiol. 572, 477 492.
49. Uchihara T., Akiyama H., Kondo H. Ikeda K. (1997) Activated microglial cells are colocalized with perivascular deposits of amyloid-β protein in Alzheimer's disease brain. Stroke 28, 1948 1950.
50. Van Nostrand W. E., Melchor J. P. Ruffini L. (1998) Pathologic amyloid β-protein cell surface fibril assembly on cultured human cerebrovascular smooth muscle cells. J. Neurochem. 70, 216 223.
51. Verdier Y., Zarandi M. Penke B. (2004) Amyloid β-peptide interactions with neuronal and glial cell plasma membrane: binding sites and implications for Alzheimer's disease. J. Pept. Sci. 10, 229 248.
52. Walker D. G. Lue L. F. (2005) Investigations with cultured human microglia on pathogenic mechanisms of Alzheimer's disease and other neurodegenerative diseases. J. Neurosci. Res. 81, 412 425.
53. Walsh D. M. Selkoe D. J. (2007) Abeta Oligomers - a decade of discovery. J. Neurochem. 101, 1172 1184.
54. Weidenfeller C., Schrot S., Zozulya A. Galla H. J. (2005) Murine brain capillary endothelial cells exhibit improved barrier properties under the influence of hydrocortisone. Brain Res. 1053, 162 174.
55. White J. A., Manelli A. M., Holmberg K. H., Van Eldik L. J. Ladu M. J. (2005) Differential effects of oligomeric and fibrillar amyloid-β 1-42 on astrocyte-mediated inflammation. Neurobiol. Dis. 18, 459 465.
56. Wogulis M., Wright S., Cunningham D., Chilcote T., Powell K. Rydel R. E. (2005) Nucleation-dependent polymerization is an essential component of amyloid-mediated neuronal cell death. J. Neurosci. 25, 1071 1080.
57. Wright S., Malinin N. L., Powell K. A., Yednock T., Rydel R. E. Griswold-Prenner I. (2007) α2β1 and αVβ1 integrin signaling pathways mediate amyloid-β-induced neurotoxicity. Neurobiol. Aging 28, 226 237.
58. Yamada M. (2000) Cerebral amyloid angiopathy: an overview. Neuropathology 20, 8 22.
59. Yamada M., Itoh Y., Shintaku M., Kawamura J., Jensson O., Thorsteinsson L., Suematsu N., Matsushita M. Otomo E. (1996) Immune reactions associated with cerebral amyloid angiopathy. Stroke 27, 1155 1162.